Melatonin and cancer risk: Does light at night compromise physiologic cancer protection by lowering serum melatonin levels?

British Journal of Cancer

Volumn 90, Issue 5, 2004, Pages 941-943

  Schernhammer, E S ^a,b   Schulmeister, K ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c ARC SEIBERSDORF RESEARCH GMBH   (Austria)

Author keywords

Cancer; Light exposure; Melatonin; Night work

Indexed keywords

MELATONIN; PROTECTIVE AGENT;

ANTINEOPLASTIC ACTIVITY; CANCER PREVENTION; CANCER RISK; CIRCADIAN RHYTHM; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE SYNTHESIS; HUMAN; LIGHT EXPOSURE; NIGHT; NIGHT WORK; OCCUPATIONAL HEALTH; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT SURVEY; SUPRACHIASMATIC NUCLEUS; UNITED STATES;

ANIMALS; CIRCADIAN RHYTHM; HUMANS; LIGHT; MELATONIN; NEOPLASMS; RISK FACTORS;

EID: 1942456603     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601626     Document Type: Short Survey

References (42)

1. Anisimov VN, Kvetnoy IM, Chumakova NK, Kvetnaya TV, Molotkov AO, Pogudina NA, Popovich IG, Popuchiev VV, Zabezhinski MA, Bartsch H, Bartsch C (1999) Melatonin and colon carcinogenesis. Exp Toxicol Pathol 51: 47-52
2. Anisimov VN, Popovich IG, Shtylik AV, Zabezhinski MA, Ben-Huh H, Gurevich P, Berman V, Tendler Y, Zusman I (2000a) Melatonin and colon carcinogenesis. III. Effect of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced by 1,2-dimethylhydrazine in rats. Exp Toxic Pathol 52: 71-76
3. Anisimov VN, Popovich IG, Zabezhinski MA (1997) Melatonin and colon carcinogenesis: I. Inhibitory effect of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats. Carcinogenesis 18: 1549-1553
4. Anisimov VN, Zabezhinski MA, Popovich IG, Zaripova EA, Musatov SA, Andre V, Vigreux C, Godard T, Sichel F (2000b) Inhibitory effect of melatonin on 7, 12-dimethylbenz[a]anthracene-induced carcinogenesis of the uterine cervix and vagina in mice and mutagenesis in vitro. Cancer Lett 156: 199-205
5. Boggild H, Knutsson A (1999) Shift work, risk factors and cardiovascular disease. Scand J Work Environ Health 25: 85-99
6. Brzezinski A (1997) Melatonin in humans. N Engl J Med 336: 186-195
7. Cini G, Coronnello M, Mini E, Neri B (1998) Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat. Cancer Lett 125: 51-59
8. Cohen M, Lippman M, Chabner B (1978) Role of pineal gland in aetiology and treatment of breast cancer. Lancet 2: 814-816
9. Cos S, Fernandez F, Sanchez-Barcelo EJ (1996) Melatonin inhibits DNA synthesis in MCF-7 human breast cancer cells in vitro. Life Sci 58: 2447-2453
10. Cos S, Fernandez R, Guezmes A, Sanchez-Barcelo EJ (1998) Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res 58: 4383-4390
11. Cos S, Mediavilla MD, Fernandez R, Gonzalez-Lamuno D, Sanchez-Barcelo EJ (2002) Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro? J Pineal Res 32: 90-96
12. Costa G (1997) The problem: shiftwork. Chronobiol Int 14: 89-98
13. Czeisler CA, Klerman EB (1999) Circadian and sleep-dependent regulation of hormone release in humans. Recent Prog Horm Res 54: 97-130
14. Davis S, Mirick DK, Stevens RG (2001) Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93: 1557-1562
15. Garland FC, Garland CF, Gorham ED, Young JF (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19: 614-622
16. Graham C, Cook MR (2001) Examination of the melatonin hypothesis in women exposed at night to EMF or bright light. Environ Health Perspect 109: 501-507
17. Hansen J (2001) Increased breast cancer risk among women who work predominantly at night. Epidemiology 12: 74-77
18. Hill SM, Blask DE (1988) Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 48: 6121-6126
19. Kanishi Y, Kobayashi Y, Noda S, Ishizuka B, Saito K (2000) Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines. J Pineal Res 28: 227-233
20. Kerenyi NA, Pandula E, Feuer G (1990) Why the incidence of cancer is increasing: the role of 'light pollution'. Med Hypotheses 33: 75-78
21. Laufer GE, Matzkin H, Zisapel N (1999) Melatonin receptors in PC3 human prostate tumor cells. J Pineal Res 26: 211-220
22. Mediavilla MD, Cos S, Sanchez-Barcelo EJ (1999) Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sci 65:415-420
23. Mocchegiani E, Perissin L, Santarelli L, Tibaldi A, Zorzet S, Rapozzi V, Giacconi R, Bulian D, Giraldi T (1999) Melatonin administration in tumor-bearing mice (intact and pinealectomized) in relation to stress, zinc, thymulin and IL-2. Int J Immunopharmacol 21: 27-46
24. Musatov SA, Anisimov VN, Andre V, Vigreux C, Godard T, Sichel F (1999) Effects of melatonin on N-nitroso-N-methylurea-induced carcinogenesis in rats and mutagenesis in vitro (Ames test and COMET assay). Cancer Lett 138: 37-44
25. Panzer A, Lottering ML, Bianchi P, Glencross DK, Stark JH, Seegers JC (1998) Melatonin has no effect on the growth, morphology or cell cycle of human breast cancer (MCF-7), cervical cancer (HeLa), osteosarcoma (MG-63) or lymphoblastoid (TK6) cells. Cancer Lett 122: 17-23
26. Petranka J, Baldwin WS, Bierman J, Jayadev S, Barrett JC, Murphy E (1999) The oncostatic action of melatonin in an ovarian carcinoma cell line. Pineal Res 26: 129-136
27. Pukkala E, Auvinen H, Wahlberg G (1995) Incidence of cancer among Finnish airline cabin attendants. Br Med J 311: 649-652
28. Rafnsson V, Tulinius H, Jonasson JG, Hrafnkelsson J (2001) Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 12: 95-101
29. Schernhammer ES, Hankinson SE (2003) Light at night: a novel risk factor for cancer in shift workers? Clin Occup Environ Med 3: 263-278
30. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Colditz GA (2001) Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. J Natl Cancer Inst 93: 1563-1568
31. Shiu SY, Li L, Xu JN, Pang CS, Wong JT, Pang SF (1999) Melatonin-induced inhibition of proliferation and G1/S cell cycle transition delay of human choriocarcinoma JAr cells: possible involvement of MT2 (MEL1B) receptor. Pineal Res 27: 183-192
32. Snyder SH, Axelrod J, Zweig M (1967) Circadian rhythm in the serotonin content of the rat pineal gland: regulating factors. J Pharmacol Exp Ther 158: 206-213
33. Spiegel D, Sephton S (2002) Re: Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 94: 530
34. Stevens RG (1987) Electric power use and breast cancer: a hypothesis. Am J Epidemiol 125: 556-561
35. Sze SF, Ng TB, Liu WK (1993) Antiproliferative effect of pineal indoles on cultured tumor cell lines. J Pineal Res 14: 27-33
36. Tamarkin L, Cohen M, Roselle D, Reichert C, Lippman M, Chabner B (1981) Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a) anthracene-induced mammary tumors in the rat. Cancer Res 41: 4432-4436
37. Tynes T, Hannevik M, Andersen A, Vistnes A, Haldorsen T (1996) Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 7: 197-204
38. Vener KJ, Szabo S, Moore JG (1989) The effect of shift work on gastrointestinal (GI) function: a review. Chronobiologia 16: 421-439
39. Vijayalaxmi, Thomas CRJ, Reiter RJ, Herman TS (2002) Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 20: 2575-2601
40. Weitzman ED, Czeisler CA, Zimmerman JC, Moore-Ede MC (1981) Biological rhythms in man: relationship of sleep - wake, cortisol, growth hormone, and temperature during temporal isolation. Adv Biochem Psychopharmacol 28: 475-499
41. Ying SW, Niles LP, Crocker C (1993) Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin. Eur J Pharmacol 246: 89-96
42. Zeitzer JM, Dijk DJ, Kronauer R, Brown E, Czeisler C (2000) Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J Physiol 526: 695-702